Figure 3.
Figure 3. Kaplan-Meier curves for univariate analysis, irrespective of treatment approach. Stratified by (A) JAK2/MPL vs CALR vs triple-negative patients, (B) cytogenetic abnormalities, (C) TP53 mutation, and (D) number of mutations.

Kaplan-Meier curves for univariate analysis, irrespective of treatment approach. Stratified by (A) JAK2/MPL vs CALR vs triple-negative patients, (B) cytogenetic abnormalities, (C) TP53 mutation, and (D) number of mutations.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal